Taddese Desta

657 total citations
7 papers, 382 citations indexed

About

Taddese Desta is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Taddese Desta has authored 7 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Taddese Desta's work include Esophageal and GI Pathology (3 papers), Gallbladder and Bile Duct Disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Taddese Desta is often cited by papers focused on Esophageal and GI Pathology (3 papers), Gallbladder and Bile Duct Disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Taddese Desta collaborates with scholars based in United States, Canada and France. Taddese Desta's co-authors include Daniel Quirk, Cynthia Schaeffer, Felix Tiongco, Brooks D. Cash, K. Peter Etzkorn, David Bernstein, Douglas K. Rex, Joseph W. Leung, John F. Inciardi and Shelby Sullivan and has published in prestigious journals such as Journal of Hepatology and Gastrointestinal Endoscopy.

In The Last Decade

Taddese Desta

7 papers receiving 366 citations

Peers

Taddese Desta

APM

SURGE

CCICM

EPIDE

PRM

Kong South Korea

Miao Zhou China

Rob Spanjersberg Netherlands

A. Mathieu United States

Carlos J. Pérez-Rivera Colombia

Joke Nollet Belgium

Guillaume Lacave France

Thorsten Brechmann Germany

Gholamreza Khalili Iran

Kong South Korea

Taddese Desta

74 ×0.4

APM

92 ×0.6

SURGE

36 ×0.3

CCICM

53 ×0.7

EPIDE

53 ×0.8

PRM

Citations per year, relative to Taddese Desta Taddese Desta (= 1×) peers Kong

Countries citing papers authored by Taddese Desta

Since Specialization

Citations

This map shows the geographic impact of Taddese Desta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taddese Desta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taddese Desta more than expected).

Fields of papers citing papers by Taddese Desta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taddese Desta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taddese Desta. The network helps show where Taddese Desta may publish in the future.

Co-authorship network of co-authors of Taddese Desta

This figure shows the co-authorship network connecting the top 25 collaborators of Taddese Desta. A scholar is included among the top collaborators of Taddese Desta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taddese Desta. Taddese Desta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ratziu, Vlad, Mary E. Rinella, Brent A. Neuschwander‐Tetri, et al.. (2021). EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study. Journal of Hepatology. 76(3). 506–517. 87 indexed citations

2.

Ratziu, Vlad, Mary E. Rinella, Brent Tetri, et al.. (2020). EDP-305, a non-bile acid farnesoid X receptor (FXR) agonist, showed statistically significant improvements in liver biochemistry and hepatic steatosis in the phase 2a argon-1 study. Journal of Hepatology. 73. S56–S57. 5 indexed citations

3.

Rex, Douglas K., Raj Bhandari, Taddese Desta, et al.. (2018). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointestinal Endoscopy. 88(3). 427–437.e6. 196 indexed citations

4.

Leung, Joseph W., Yanlei Liu, Taddese Desta, et al.. (2000). In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage. Gastrointestinal Endoscopy. 51(3). 296–303. 33 indexed citations

5.

Leung, Joseph W., et al.. (1998). Is there a synergistic effect between mixed bacterial infection in biofilm formation on biliary stents?. Gastrointestinal Endoscopy. 48(3). 250–257. 57 indexed citations

6.

Lam, Kit S., et al.. (1996). Is there a synergistic effect of mixed bacterial infection in biliary stent blockage?. Gastrointestinal Endoscopy. 43(4). 385–385. 2 indexed citations

7.

Desta, Taddese, et al.. (1996). Long term ciprofloxacin prophylaxis in the prevention of stent blockage. Gastrointestinal Endoscopy. 43(4). 379–379. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact